CBT
RIGL icon

Capital Bank & Trust’s Rigel Pharmaceuticals RIGL Stock Holding History

Capital Bank & Trust’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5
Closed – – 566
2020
Q1 		$0 Hold
5
– – ﹤0.01% 772
2019
Q4 		$0 Hold
5
– – ﹤0.01% 819
2019
Q3 		$0 Hold
5
– – ﹤0.01% 841
2019
Q2 		$0 Hold
5
– – ﹤0.01% 727
2019
Q1 		$0 Hold
5
– – ﹤0.01% 766
2018
Q4 		$0 Hold
5
– – ﹤0.01% 811
2018
Q3 		$0 Hold
5
– – ﹤0.01% 826
2018
Q2 		$0 Hold
5
– – ﹤0.01% 721
2018
Q1 		$0 Hold
5
– – ﹤0.01% 692
2017
Q4 		$0 Hold
5
– – ﹤0.01% 729
2017
Q3 		$0 Hold
5
– – ﹤0.01% 622
2017
Q2 		$0 Buy
+5
New +$137 ﹤0.01% 580

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Bank & Trust's RIGL Position: Q2 2020 in Review

Capital Bank & Trust sold out of Rigel Pharmaceuticals (RIGL) in Q2 2020, closing a stake of 5 shares.

Capital Bank & Trust first reported a position in RIGL in Q2 2017 and held it in 12 quarters. The position peaked at $0 in Q1 2020. 135 funds tracked by Wall St. Rank hold RIGL as of Q2 2020.

  • Capital Bank & Trust reported no remaining Rigel Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Capital Bank & Trust sold 5 Rigel Pharmaceuticals shares in Q2 2020.
  • Capital Bank & Trust first reported a position in Rigel Pharmaceuticals in Q2 2017 and held it in 12 quarters.
  • Capital Bank & Trust's Rigel Pharmaceuticals position peaked at $0 in Q1 2020.
  • 135 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2020.

Based on Capital Bank & Trust's 13F filing for Q2 2020, filed 14 Aug 2020.